Suzetrigine
Suzetrigine is listed in the FDA National Drug Code directory with 11 NDC codes, marketed under brand name including JOURNAVX. Available dosage forms: powder, tablet, film coated.
Drug details
- Generic Name
- Suzetrigine
- Brand Names
- JOURNAVX
- Application Number
- NDA219209
- Sponsor
- Shanghai SynTheAll Pharmaceutical Co., Ltd.
- NDC Codes
- 11
- Dosage Forms
- POWDER, TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- SUZETRIGINE
Indications and Usage
1 INDICATIONS AND USAGE JOURNAVX is indicated for the treatment of moderate to severe acute pain, including postoperative pain, in adults. JOURNAVX is a sodium channel blocker indicated for the treatment of moderate to severe acute pain, including postoperative pain, in adults. ( 1 )